UPDATE 1-Horizon Pharma raises offer for Depomed
July 21, 2015 at 07:44 AM EDT
July 21 (Reuters) - Ireland-based Horizon Pharma Plc raised its offer to buy Depomed Inc to $33 per share, contingent on the smaller drugmaker agreeing to start takeover talks.
